Clinical Trial Update: A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind trial evaluating duloxetine in outpatients with major depressive disorder and concomitant pain; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED